相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Serum metabolomic profiling in patients with Alzheimer disease and amnestic mild cognitive impairment by GC/MS
Congcong Sun et al.
BIOMEDICAL CHROMATOGRAPHY (2020)
Dysregulation of multiple metabolic networks related to brain transmethylation and polyamine pathways in Alzheimer disease: A targeted metabolomic and transcriptomic study
Uma V. Mahajan et al.
PLOS MEDICINE (2020)
Targeted mass spectrometry to quantify brain-derived cerebrospinal fluid biomarkers in Alzheimer's disease
Maotian Zhou et al.
CLINICAL PROTEOMICS (2020)
Integrated analysis of ultra-deep proteomes in cortex, cerebrospinal fluid and serum reveals a mitochondrial signature in Alzheimer's disease
Hong Wang et al.
MOLECULAR NEURODEGENERATION (2020)
Proteome profiling in cerebrospinal fluid reveals novel biomarkers of Alzheimer's disease
Jakob M. Bader et al.
MOLECULAR SYSTEMS BIOLOGY (2020)
Proteomic Profiling of Extracellular Vesicles Derived from Cerebrospinal Fluid of Alzheimer's Disease Patients: A Pilot Study
Satoshi Muraoka et al.
CELLS (2020)
Impact of gut microbiota on neurological diseases: Diet composition and novel treatments
Ana Larroya-Garcia et al.
CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION (2019)
Mass spectrometry is a multifaceted weapon to be used in the battle against Alzheimer's disease: Amyloid beta peptides and beyond
Giuseppe Grasso
MASS SPECTROMETRY REVIEWS (2019)
Extracellular Vesicle as a Source of Alzheimer's Biomarkers: Opportunities and Challenges
Seongju Lee et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Altered microRNAs related to synaptic function as potential plasma biomarkers for Alzheimer's disease
Dolores Siedlecki-Wullich et al.
ALZHEIMERS RESEARCH & THERAPY (2019)
A Systematic Review of MicroRNA Expression as Biomarker of Late-Onset Alzheimer's Disease
Soraya Herrera-Espejo et al.
MOLECULAR NEUROBIOLOGY (2019)
miR-146a and miR-181a are involved in the progression of mild cognitive impairment to Alzheimer's disease
Abulaish Ansari et al.
NEUROBIOLOGY OF AGING (2019)
MicroRNA-200a-3p Mediates Neuroprotection in Alzheimer-Related Deficits and Attenuates Amyloid-Beta Overproduction and Tau Hyperphosphorylation via Coregulating BACE1 and PRKACB
Linlin Wang et al.
FRONTIERS IN PHARMACOLOGY (2019)
Differential expression of microRNAs in Alzheimer's disease brain, blood, and cerebrospinal fluid
Petros Takousis et al.
ALZHEIMERS & DEMENTIA (2019)
Mass spectrometry: A platform for biomarker discovery and validation for Alzheimer's and Parkinson's diseases
Eugene M. Cilento et al.
JOURNAL OF NEUROCHEMISTRY (2019)
miRBase: from microRNA sequences to function
Ana Kozomara et al.
NUCLEIC ACIDS RESEARCH (2019)
Alzheimer's disease in the omics era
Giulia M. Sancesario et al.
CLINICAL BIOCHEMISTRY (2018)
Potential Novel Approaches to Understand the Pathogenesis and Treat Alzheimer's Disease
Eleanor Drummond et al.
JOURNAL OF ALZHEIMERS DISEASE (2018)
Application of Metabolomics in Alzheimer's Disease
Jordan Maximillian Wilkins et al.
FRONTIERS IN NEUROLOGY (2018)
Alzheimer Disease
Maileen Gloriane Ulep et al.
JNP-JOURNAL FOR NURSE PRACTITIONERS (2018)
Alzheimer's disease hypothesis and related therapies
Xiaoguang Du et al.
TRANSLATIONAL NEURODEGENERATION (2018)
Next-generation biomarker discovery in Alzheimer's disease using metabolomics - from animal to human studies
Marina Olle Hurtado et al.
BIOANALYSIS (2018)
Deciphering acute coronary syndrome biomarkers: High-resolution proteomics in platelets, thrombi and microparticles
Diana Navas-Carrillo et al.
CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES (2017)
Proteomic studies of cerebrospinal fluid biomarkers of Alzheimer's disease: an update
Erik Portelius et al.
EXPERT REVIEW OF PROTEOMICS (2017)
MicroRNA-455-3p as a potential peripheral biomarker for Alzheimer's disease
Subodh Kumar et al.
HUMAN MOLECULAR GENETICS (2017)
The Cerebrospinal Fluid Aβ1-42/Aβ1-40 Ratio Improves Concordance with Amyloid-PET for Diagnosing Alzheimer's Disease in a Clinical Setting
Ellis Niemantsverdriet et al.
JOURNAL OF ALZHEIMERS DISEASE (2017)
Extracellular vesicles: Novel promising delivery systems for therapy of brain diseases
David Rufino-Ramos et al.
JOURNAL OF CONTROLLED RELEASE (2017)
Mass-Spectrometry-Based Method To Quantify in Parallel Tau and Amyloid β 1-42 in CSF for the Diagnosis of Alzheimer's Disease
Gwenael Pottiez et al.
JOURNAL OF PROTEOME RESEARCH (2017)
ApoE4 markedly exacerbates tau-mediated neurodegeneration in a mouse model of tauopathy
Yang Shi et al.
NATURE (2017)
What success can teach us about failure: the plasma metabolome of older adults with superior memory and lessons for Alzheimer′s disease
Mark Mapstone et al.
NEUROBIOLOGY OF AGING (2017)
Nutrition and AGE-ing: Focusing on Alzheimer's Disease
Giulia Abate et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2017)
Data Descriptor: Targeted metabolomics and medication classification data from participants in the ADNI1 cohort
Lisa St John-Williams et al.
SCIENTIFIC DATA (2017)
High-resolution proteomics and metabolomics in thyroid cancer: Deciphering novel biomarkers
Diana Navas-Carrillo et al.
CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES (2017)
Association of amine biomarkers with incident dementia and Alzheimer's disease in the Framingham Study
Vincent Chouraki et al.
ALZHEIMERS & DEMENTIA (2017)
The future of NMR-based metabolomics
John L. Markley et al.
CURRENT OPINION IN BIOTECHNOLOGY (2017)
The amyloid hypothesis of Alzheimer's disease at 25years
Dennis J. Selkoe et al.
EMBO MOLECULAR MEDICINE (2016)
Metabolomics studies in brain tissue: A review
Carolina Gonzalez-Riano et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2016)
High Resolution Discovery Proteomics Reveals Candidate Disease Progression Markers of Alzheimer's Disease in Human Cerebrospinal Fluid
Ronald C. Hendrickson et al.
PLOS ONE (2015)
An Integrated Workflow for Multiplex CSF Proteomics and Peptidomics-Identification of Candidate Cerebrospinal Fluid Biomarkers of Alzheimer's Disease
Mikko Holtta et al.
JOURNAL OF PROTEOME RESEARCH (2015)
Untargeted Metabolomic Analysis of Human Plasma Indicates Differentially Affected Polyamine and L-Arginine Metabolism in Mild Cognitive Impairment Subjects Converting to Alzheimer's Disease
Stewart F. Graham et al.
PLOS ONE (2015)
Familial nonmedullary thyroid cancer: Screening, clinical, molecular and genetic findings
Diana Navas-Carrillo et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2014)
MicroRNAs in Plasma and Cerebrospinal Fluid as Potential Markers for Alzheimer's Disease
Takehiro Kiko et al.
JOURNAL OF ALZHEIMERS DISEASE (2014)
Proteomic analysis of cerebrospinal fluid extracellular vesicles: A comprehensive dataset
Davide Chiasserini et al.
JOURNAL OF PROTEOMICS (2014)
Identification of longitudinally dynamic biomarkers in Alzheimer's disease cerebrospinal fluid by targeted proteomics
Kristin R. Wildsmith et al.
MOLECULAR NEURODEGENERATION (2014)
miRNAs in development and pathogenesis of the nervous system
Jakub S. Nowak et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2013)
Role of microRNAs in cardiac remodelling: New insights and future perspectives
Esteban Orenes-Pinero et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2013)
A Selected Reaction Monitoring (SRM)-Based Method for Absolute Quantification of A beta(38), A beta(40), and A beta(42) in Cerebrospinal Fluid of Alzheimer's Disease Patients and Healthy Controls
Josef Pannee et al.
JOURNAL OF ALZHEIMERS DISEASE (2013)
Non-coding RNAs in Alzheimer's Disease
Lin Tan et al.
MOLECULAR NEUROBIOLOGY (2013)
Proteomic Changes in Cerebrospinal Fluid of Presymptomatic and Affected Persons Carrying Familial Alzheimer Disease Mutations
John M. Ringman et al.
ARCHIVES OF NEUROLOGY (2012)
Reference measurement procedures for Alzheimer's disease cerebrospinal fluid biomarkers: definitions and approaches with focus on amyloid β42
Niklas Mattsson et al.
BIOMARKERS IN MEDICINE (2012)
MicroRNA-101 downregulates Alzheimer's amyloid-β precursor protein levels in human cell cultures and is differentially expressed
Justin M. Long et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2011)
Adult hippocampal neurogenesis and its role in Alzheimer's disease
Yangling Mu et al.
MOLECULAR NEURODEGENERATION (2011)
Plasma apolipoprotein E and Alzheimer disease risk The AIBL study of aging
V. B. Gupta et al.
NEUROLOGY (2011)
Shotgun Mass Spectrometry Workflow Combining IEF and LC-MALDI-TOF/TOF
Giuseppina Maccarrone et al.
PROTEIN JOURNAL (2010)
MicroRNA-298 and MicroRNA-328 Regulate Expression of Mouse β-Amyloid Precursor Protein-converting Enzyme 1
Vincent Boissonneault et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Alzheimer's disease beyond the genomic era: nuclear magnetic resonance (NMR) spectroscopy-based metabolomics
Ignasi Barba et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2008)
Loss of microRNA cluster miR-29a/b-1 in sporadic Alzheimer's disease correlates with increased BACE1/β-secretase expression
Sebastien S. Hebert et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Searching urinary tumor markers for bladder cancer using a two-dimensional differential gel electrophoresis (2D-DIGE) approach
Esteban Orenes-Pinero et al.
JOURNAL OF PROTEOME RESEARCH (2007)
Micro-RNA speciation in fetal, adult and Alzheimer's disease hippocampus
Walter J. Lukiw
NEUROREPORT (2007)
Kinases and phosphatases and tau sites involved in Alzheimer neurofibrillary degeneration
Jian-Zhi Wang et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2007)
CSF Aβ 42 levels correlate with amyloid-neuropathology in a population-based autopsy study
D Strozyk et al.
NEUROLOGY (2003)
Amyloid beta-protein (A beta)1-40 protects neurons from damage induced by A beta 1-42 in culture and in rat brain
K Zou et al.
JOURNAL OF NEUROCHEMISTRY (2003)
Role of apoE/Aβ interactions in the pathogenesis of Alzheimer's disease and cerebral amyloid angiopathy
DM Holtzman
JOURNAL OF MOLECULAR NEUROSCIENCE (2001)
分享论文
